VM
Vandanaben Maheshbhai Matholiya
About Vandanaben Maheshbhai Matholiya
Data last updated:
Vandanaben Maheshbhai Matholiya is a Director at Augxen Pharma Private Limited (since 2021). The company operates in Pharma. Augxen Pharma Private Limited reported revenue of ₹27.52 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Augxen Pharma Private Limited U33110GJ2021PTC124296 | Director | 22 Jul 2021 | 2021 | ₹27.52 Cr (FY 2025) | Active |
Board colleagues of Vandanaben Maheshbhai Matholiya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gajera Manishaben Vijaybhai | 09250068 | Augxen Pharma Private Limited | Director |
| Hardik Bhadabhai Soliya | 09009045 | Augxen Pharma Private Limited | Director |
| Ranjanaben Patil | 09250066 | Augxen Pharma Private Limited | Director |
| Savanbhai Devchandbhai Tibadiya | 09009044 | Augxen Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vandanaben Maheshbhai Matholiya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vandanaben Maheshbhai Matholiya
Vandanaben Maheshbhai Matholiya currently holds 1 directorship: Augxen Pharma Private Limited (Director, since 22 Jul 2021, revenue ₹27.52 Cr (FY 2025)).
Vandanaben Maheshbhai Matholiya was first appointed on 22 Jul 2021 as Director at Augxen Pharma Private Limited.
The current boards of Vandanaben Maheshbhai Matholiya's companies include Gajera Manishaben Vijaybhai (Augxen Pharma Private Limited), Hardik Bhadabhai Soliya (Augxen Pharma Private Limited), Ranjanaben Patil (Augxen Pharma Private Limited), Savanbhai Devchandbhai Tibadiya (Augxen Pharma Private Limited).